Fig. 4: A drug-induced RRM2 to RRM2B subunit switch in HB cells in vitro.
From: Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse
a The dose-response curves of HepG2 and HB214 cells treated with the indicated chemotherapeutic agents and RRM2 inhibitors (n = 3 for each group). b RRM2 and RRM2B immunoblotting HepG2 and HB214 cells with the indicated drugs.
